Skip to content

Atairos Partners GP, Inc.

Follow

13F filer, CIK 1671176, Bryn Mawr, PA

Atairos Partners GP, Inc. reported $41,103,514 across 2 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950103-26-012368

Period
2026-06-30
Reported value
$41.1M
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0000950103-26-012368, largest first. % of portfolio is the value over $41,103,514, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CLVTCLARIVATE PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 3,465,000 shares; 2025Q1: 3,465,000 shares; 2025Q2: 3,465,000 shares; 2025Q3: 3,465,000 shares; 2025Q4: 10,232,667 shares; 2026Q1: 10,232,667 shares; 2026Q2: 10,232,667 shares 10,232,667$22.1M53.77%0Timeline
ADVADVANTAGE SOLUTIONS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 10,985,759 shares; 2024Q4: 10,985,759 shares; 2025Q1: 10,985,759 shares; 2025Q2: 10,985,759 shares; 2025Q3: 10,985,759 shares; 2025Q4: 10,985,759 shares; 2026Q1: 439,430 shares; 2026Q2: 439,430 shares 439,430$19M46.23%0Timeline

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950103-26-012368 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0000950103-26-012368 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0000950103-26-007248 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0000950103-26-002193 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0000950103-25-014725 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0000950103-25-010284 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0000950103-25-006039 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0000950103-25-002069 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0000950103-24-016276 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0000950103-24-012205 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0000950103-24-006712 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0000950103-24-002203 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR/A 0000950103-23-016376 Quarter ended 2022-03-312023-11-16acceptance time not in the bulk data set
13F-HR 0000950103-23-016257 Quarter ended 2023-09-302023-11-15acceptance time not in the bulk data set
13F-HR 0000950103-23-016249 Quarter ended 2023-03-312023-11-14acceptance time not in the bulk data set
13F-HR 0000950103-23-013333 Quarter ended 2022-03-312023-09-06acceptance time not in the bulk data set
13F-HR 0000950103-23-013334 Quarter ended 2022-12-312023-09-06acceptance time not in the bulk data set
13F-HR 0000950103-23-012018 Quarter ended 2023-06-302023-08-15acceptance time not in the bulk data set